Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma.
about
Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer developmentCross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic ImplicationsPLK1, A Potential Target for Cancer TherapyTargeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancersUpregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal CancerCurrent progress of siRNA/shRNA therapeutics in clinical trials.Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcomMolecular classification and biomarker discovery in papillary thyroid carcinoma.FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients.The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.The role of polo-like kinase 1 in carcinogenesis: cause or consequence?Unconventional Functions of Mitotic Kinases in Kidney Tumorigenesis.Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.Transcriptional landscape of human cancers.Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma.Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.Polo-like kinase 1 expression is a prognostic factor in human colon cancer.Real-time fluorescent quantitative polymerase chain reaction study of polo-like kinase-1 in pterygia.The balance of Polo-like kinase 1 in tumorigenesis.The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis.Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features.Expression of PLK1 and survivin in non-Hodgkin's lymphoma treated with CHOP.Expression of PLK1 and survivin in diffuse large B-cell lymphoma.Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.DNA-PKcs associates with PLK1 and is involved in proper chromosome segregation and cytokinesis.Expression patterns of polo-like kinase 1 in human gastric cancer.Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma.CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
P2860
Q26825016-3E067FBD-55FA-4F01-8826-7ADFBC29DF0EQ28076060-75ED8212-CC40-4C73-8EC9-538B3822236BQ28078772-A5EC9BCB-8898-4A1C-9F71-BF9F5576B549Q33564389-D3EFFCFB-6BAF-4CDC-B9C8-26967D67EE8FQ33728889-62C0DF49-D9C8-4CC3-90ED-3841F1F33532Q35654260-02734B41-7C3A-4EEC-BB3F-58CA6B859AE3Q36071638-4F56E40B-259B-4A0E-8A18-C1AC9125D1E9Q36245509-C846A709-5C67-4363-A686-D15C656871E7Q36299916-F9967AFC-55D0-416C-BF24-855C5F387577Q36741118-974B8163-E4C9-4894-ADA6-A5BD1275B9D3Q37335160-4AA7A120-6E36-4105-83A7-2266F8E4FD6EQ37701672-EF8D18EF-CE93-4025-979C-4088FEF4F50AQ38165149-5C6A5F7F-BB52-41BA-A74B-7D863F590E2CQ38637013-4819ACE7-F374-4D55-9BEA-AA7CBFBA01DCQ38657693-CE46314A-330A-4B6F-92F5-86D5B3117B08Q38828328-022D43A4-3D7B-4664-A5CB-C6868A0A5DA3Q39004661-800FE088-093F-4B86-8E03-5FDD0BCC4225Q39633115-4E554495-333D-443E-BB85-6B0703D592E4Q40286351-0D27B8CC-69E9-4847-A0C3-A13A61DB24A7Q40359903-697AC9E6-ADC5-45B4-B5F0-EEAD33C40D98Q43166183-96435D6A-84B2-4088-815A-45201753D4D2Q43180721-6A6302E1-ADAC-4BA6-8E72-493B8FD81527Q45068538-2D0F9463-BDD4-42EB-9980-0481DCD84145Q46674063-DB1DA457-7A8C-4821-9DB8-A2231A1E250CQ46734559-73B256F4-2CAF-4180-864D-D73C02F73E67Q46944600-918E6886-2660-4711-B43F-77636799F369Q50580168-570C5EFC-3F43-4B5F-B57D-96FF639343FAQ53090357-C82A4143-0CD7-474C-A03C-0AAC8A2BCA74Q53626405-A369C5C1-EF35-4E66-A05D-3A34F5F935F7Q54979207-FF04618B-E2C3-4F5C-9058-B0F803229EB4Q58779939-62DB6E8F-8AE3-49F4-9B8D-147AA94DF883
P2860
Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@ast
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@en
type
label
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@ast
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@en
prefLabel
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@ast
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@en
P2093
P2860
P356
P1476
Polo-like kinase 1 overexpress ...... ession of papillary carcinoma.
@en
P2093
A Miyauchi
F Matsuzuka
K Kobayashi
N Matsuura
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601540
P407
P577
2004-01-01T00:00:00Z